Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umar Mahmood

Showing results (111-120 of 213) with videos related to

Pageof 22
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Optical imaging with a novel cathepsin-activatable probe for enhanced detection of colorectal cancerShadi A Esfahani, Pedram Heidari, Melanie H Kucherlapati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET ImagingBenjamin M Larimer, Emily Bloch, Sarah Nesti, et al.
Bone|November 15, 2008
Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivoKenneth M Kozloff, Luisa Quinti, Somying Patntirapong, et al.
Cancer Gene Therapy|March 8, 2023
Correction to: Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastasesDarshini Kuruppu, Deepak Bhere, Christian T Farrar, et al.
American Journal of Nuclear Medicine and Molecular Imaging|August 11, 2016
Design, construction and testing of a low-cost automated (68)Gallium-labeling synthesis unit for clinical usePedram Heidari, Alicia Szretter, Laura E Rushford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degraderPedram Heidari, Francis Deng, Shadi A Esfahani, et al.
EJNMMI Radiopharmacy and Chemistry|December 29, 2025
Developing a theranostic nanobody targeting FAP for cancer imaging and therapyLital Ben-Naim, Suma Prabhu, Miguel Ferreira, et al.
Cancer Gene Therapy|February 1, 2023
Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastasesDarshini Kuruppu, Deepak Bhere, Christian T Farrar, et al.
Breast Cancer Research : BCR|July 2, 2024
A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidanceNicoleta Sinevici, Christine E Edmonds, Brian N Dontchos, et al.
Cancer Research|May 3, 2017
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy ResponseBenjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, et al.
Pageof 22

Showing results (111-120 of 213) with videos related to

Sort By:
Pageof 22
American Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Optical imaging with a novel cathepsin-activatable probe for enhanced detection of colorectal cancerShadi A Esfahani, Pedram Heidari, Melanie H Kucherlapati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET ImagingBenjamin M Larimer, Emily Bloch, Sarah Nesti, et al.
Bone|November 15, 2008
Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivoKenneth M Kozloff, Luisa Quinti, Somying Patntirapong, et al.
Cancer Gene Therapy|March 8, 2023
Correction to: Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastasesDarshini Kuruppu, Deepak Bhere, Christian T Farrar, et al.
American Journal of Nuclear Medicine and Molecular Imaging|August 11, 2016
Design, construction and testing of a low-cost automated (68)Gallium-labeling synthesis unit for clinical usePedram Heidari, Alicia Szretter, Laura E Rushford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degraderPedram Heidari, Francis Deng, Shadi A Esfahani, et al.
EJNMMI Radiopharmacy and Chemistry|December 29, 2025
Developing a theranostic nanobody targeting FAP for cancer imaging and therapyLital Ben-Naim, Suma Prabhu, Miguel Ferreira, et al.
Cancer Gene Therapy|February 1, 2023
Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastasesDarshini Kuruppu, Deepak Bhere, Christian T Farrar, et al.
Breast Cancer Research : BCR|July 2, 2024
A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidanceNicoleta Sinevici, Christine E Edmonds, Brian N Dontchos, et al.
Cancer Research|May 3, 2017
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy ResponseBenjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, et al.
Pageof 22